<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2-5130-19
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2019
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        DIOZAD
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        VALSARTAN,HYDROCHLOROTHIAZIDE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        160,12.5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        24.5
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Macleods Pharmaceuticals Limited" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Macleods Pharmaceuticals Limited
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 1935]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Razy Al Madina Pharmaceutical
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Razy Al Madina Pharmaceutical	
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        C03AA03 
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        C09CA03 
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">Diozad film-coated tablets contain two active substances called valsartan and hydrochlorothiazide. Both of these substances help to control high blood pressure (hypertension).</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Valsartan belongs to a class of medicines known as &ldquo;angiotensin II receptor antagonists&rdquo;, which help to control high blood pressure. Angiotensin II is a substance in the body that causes vessels to tighten, thus causing your blood pressure to increase. Valsartan works by blocking the effect of angiotensin II. As a result, blood vessels relax and blood pressure is lowered.</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hydrochlorothiazide belongs to a group of medicines called thiazide diuretics (also known as &ldquo;water tablets&rdquo;). Hydrochlorothiazide increases urine output, which also lowers blood pressure.</p><p dir="ltr">Diozad is used to treat high blood pressure which is not adequately controlled by a single substance alone.</p><p dir="ltr">High blood pressure increases the workload of the heart and arteries. If not treated, it can damage the blood vessels of the brain, heart, and kidneys, and may result in a stroke, heart failure or kidney failure. High blood pressure increases the risk of heart attacks. Lowering your blood pressure to normal reduces the risk of developing these disorders.</p><p dir="ltr">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">You may take Diozad only after a medical examination. Diozad may not be suitable for all patients. Follow your doctor&rsquo;s instructions carefully. They may differ from the general information contained in the leaflet.</p><p dir="ltr"><strong>Do not take Diozad:</strong></p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you are allergic (hypersensitive) to valsartan, hydrochlorothiazide, sulphonamide derivatives (substances chemically related to hydrochlorothiazide) or to any of the other ingredients of this medicine (listed in section 6).</p><p dir="ltr">&nbsp;&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you are <strong>more than 3 months pregnant</strong> (it is also better to avoid Diozad in early pregnancy &ndash; see pregnancy section).</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have severe liver disease, destruction of the small bile ducts within the liver (biliary cirrhosis) leading to the buildup of bile in the liver (cholestasis).</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have severe kidney disease.</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you are unable to produce urine (anuria).</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you are treated with an artificial kidney.</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if the level of potassium or sodium in your blood is lower than normal, or if the level of calcium in your blood is higher than normal despite treatment.</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have gout.</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have diabetes or impaired kidney function and you are treated with a blood pressure lowering medicine containing aliskiren.</p><p dir="ltr">If any of the above apply to you, tell your doctor and do not take Diozad.</p><p dir="ltr"><strong>Warnings and precautions </strong></p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you are taking potassium-sparing medicines, potassium supplements, salt substitutes containing potassium or other medicines that increase the amount of potassium in your blood such as heparin. Your doctor may need to check the amount of potassium in your blood regularly.</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have low levels of potassium in your blood.</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have diarrhoea or severe vomiting.</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you are taking high doses of water tablets (diuretics).</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have severe heart disease.</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you are suffering from heart failure or have experienced a heart attack. Follow your doctor&rsquo;s instruction for the starting dose carefully. Your doctor may also check your kidney function.</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you suffer from a narrowing of the kidney artery.</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have recently received a new kidney.</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you suffer from hyperaldosteronism. This is a disease in which your adrenal glands make too much of the hormone aldosterone. If this applies to you, the use of Diozad is not recommended.</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have liver or kidney disease.</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have ever experienced swelling of the tongue and face caused by an allergic reaction called angioedema when taking another drug (including ACE inhibitors), tell your doctor. If these symptoms occur when you are taking Diozad, stop taking Diozad immediately and never take it again. See also section 4, &ldquo;Possible side effects&rdquo;.</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have fever, rash and joint pain, which may be signs of systemic lupus erythematosus (SLE, a so-called autoimmune disease).</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have diabetes, gout, high levels of cholesterol or triglycerides in your blood.</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have had allergic reactions with the use of other blood pressure-lowering agents of this class (angiotensin II receptor antagonists) or if you have allergy or asthma.</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you experience a decrease in vision or eye pain. These could be symptoms of fluid accumulation in the vascular layer of the eye (choroidal effusion) or an increase of pressure in your eye and can happen within hours to weeks of taking Diozad. This can lead to permanent vision loss, if not treated. If you earlier have had a penicillin or sulphonamide allergy you can be at higher risk of developing this.</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you are taking any of the following medicines used to treat high blood pressure:</p><p dir="ltr">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; an ACE inhibitors (for example enalapril, lisinopril, Ramipril), in particular if you have diabetes-related kidney problems.</p><p dir="ltr">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; aliskiren</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have had skin cancer or if you develop an unexpected skin lesion during the treatment. Treatment with hydrochlorothiazide, particularly long-term use with high doses, may increase the risk of some types of skin and lip cancer (non-melanoma skin cancer). Protect your skin from sun exposure and UV rays while taking Diozad.</p><p dir="ltr">&nbsp;Your doctor may check your kidney function, blood pressure, and the amount of electrolytes (e.g. potassium) in your blood at regular intervals.</p><p dir="ltr">See also information under the heading &ldquo;Do not take Diozad&rdquo; Diozad may cause increased sensitivity of the skin to sun.</p><p dir="ltr">The use of Diozad in children and adolescents (below the age of 18 years) is not recommended.</p><p dir="ltr">You must tell your doctor if you think you are (or might become) pregnant. Diozad is not recommended in early pregnancy, and must not be taken if you are more than 3 months pregnant, as it may cause serious harm to your baby if used at that stage (see pregnancy section).</p><p dir="ltr"><strong>Other medicines and Diozad</strong></p><p dir="ltr">Tell your doctor or pharmacist if you are taking, have recently taken any other medicines, or might take any other medicines.</p><p dir="ltr">The effect of the treatment can be influenced if Diozad is taken together with certain other medicines. It may be necessary to change the dose, to take other precautions, or in some cases to stop taking one of the medicines. This especially applies to the following medicines:</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; lithium, a medicine used to treat some types of psychiatric diseases.</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; medicines or substances that may increase the amount of potassium in your blood. These include potassium supplements or salt substitutes containing potassium, potassium-sparing medicines and heparin.</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; medicines that may reduce the amount of potassium in your blood, such as diuretics (water tablets), corticosteroids, laxatives, carbenoxolone, amphotericin or penicillin G.</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; some antibiotics (rifamycin group), a drug used to protect against transplant rejection (ciclosporin) or an antiretroviral drug used to treat HIV/AIDS infection (ritonavir). These drugs may increase the effect of Diozad.</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; medicines that may induce &ldquo;torsades de pointes&rdquo; (irregular heart beat), such as antiarrhythmics (medicines used to treat heart problems) and some antipsychotics.</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; medicines that may reduce the amount of sodium in your blood, such as antidepressants, antipsychotics, antiepileptics.</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; medicines for the treatment of gout, such as allopurinol, probenecid, sulfinpyrazone.</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; therapeutic vitamin D and calcium supplements.</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; medicines for the treatment of diabetes (oral agents such as metformin or insulins).</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; other medicines to lower your blood pressure including methyldopa, ACE inhibitors (such as enalapril, lisinopril, etc.) or aliskiren (see also information under the headings &ldquo;Do not take Diozad&rdquo; and &ldquo;Warnings and precautions&rdquo;).</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; medicines to increase blood pressure, such as noradrenaline or adrenaline.</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; digoxin or other digitalis glycosides (medicines used to treat heart problems).</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; medicines that may increase blood sugar levels, such as diazoxide or beta blockers.</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; cytotoxic medicines (used to treat cancer), such as methotrexate or cyclophosphamide.</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; pain killers such as non-steroidal anti-inflammatory agents (NSAIDs), including selective cyclooxygenase-2 inhibitors (Cox-2 inhibitors) and acetylsalicylic acid &gt; 3 g.</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; muscle relaxing medicines, such as tubocurarine.</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; anti-cholinergic medicines (medicines used to treat a variety of disorders such as gastrointestinal cramps, urinary bladder spasm, asthma, motion sickness, muscular spasms, Parkinson&#39;s disease and as an aid to anaesthesia).</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; amantadine (medicine used to treat Parkinson&rsquo;s disease and also used to treat or prevent certain illnesses caused by viruses).</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; cholestyramine and colestipol (medicines used mainly to treat high levels of lipids in the blood).</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ciclosporin, a medicine used for organ transplant to avoid organ rejection.</p><p dir="ltr">&nbsp;</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; alcohol, sleeping pills and anaesthetics (medicines with sleeping or painkilling effect used for example during surgery).</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; iodine contrast media (agents used for imaging examinations).</p><p dir="ltr"><strong>Taking Diozad with food, drink and alcohol</strong></p><p dir="ltr">Avoid taking alcohol until you have talked to your doctor. Alcohol may make your blood pressure fall more and/or increase the risk of you becoming dizzy or feeling faint.</p><p dir="ltr"><strong>Pregnancy and breast-feeding</strong></p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You must tell your doctor if you think that you are (or might become) pregnant</p><p dir="ltr">Your doctor will normally advise you to stop taking Diozad before you become pregnant or as soon as you know you are pregnant, and will advise you to take another medicine instead of Diozad. Diozad is not recommended in early pregnancy, and must not be taken when more than 3 months pregnant, as it may cause serious harm to your baby if it is used after the third month of pregnancy.</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tell your doctor if you are breast-feeding or about to start breast-feeding</p><p dir="ltr">Diozadis not recommended for mothers who are breast-feeding, and your doctor may choose another treatment for you if you wish to breast-feed, especially if your baby is newborn, or was born prematurely.</p><p dir="ltr"><strong>Driving and using machines</strong></p><p dir="ltr">Before you drive a vehicle, use tools or operate machines or carry out other activities that require concentration, make sure you know how Diozad affects you. Like many other medicines used to treat high blood pressure, Diozad may occasionally cause dizziness and affect the ability to concentrate.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">Always take this medicine exactly as your doctor has told you. This will help you to get the best results and lower the risk of side effects. Check with your doctor or pharmacist if you are not sure.</p><p dir="ltr">People with high blood pressure often do not notice any signs of this problem. Many may feel quite normal. This makes it all the more important for you to keep your appointments with your doctor even if you are feeling well.</p><p dir="ltr">Your doctor will tell you exactly how many tablets of Diozad to take. Depending on how you respond to the treatment, your doctor may suggest a higher or lower dose.</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The recommended dose of Diozad is one tablet per day.</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not change the dose or stop taking the tablets without consulting your doctor.</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The medicine should be taken at the same time each day, usually in the morning.</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You can take Diozad with or without food.</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Swallow the tablet with a glass of water.</p><p dir="ltr"><strong>If you take more Diozad than you should</strong></p><p dir="ltr">If you experience severe dizziness and/or fainting, lie down and contact your doctor immediately. If you have accidentally taken too many tablets, contact your doctor, pharmacist or hospital.</p><p dir="ltr"><strong>If you forget to take Diozad</strong></p><p dir="ltr">If you forget to take a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the dose you missed.</p><p dir="ltr">&nbsp;Do not take a double dose to make up for a forgotten dose.</p><p dir="ltr"><strong>If you stop taking Diozad</strong></p><p dir="ltr">Stopping your treatment with Diozad may cause your high blood pressure to get worse. Do not stop taking your medicine unless your doctor tells you to.</p><p dir="ltr">If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</p><p dir="ltr">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p dir="ltr">Some side effects can be serious and need immediate medical attention:</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You should see your doctor immediately if you experience symptoms of angioedema, such &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;as:</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; swollen face, tongue or pharynx</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; difficulty in swallowing</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; hives and difficulties in breathing</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Severe skin disease that causes rash, red skin, blistering of the lips, eyes or mouth, skin peeling, fever (toxic epidermal necrolysis)</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Decrease in vision or pain in your eyes due to high pressure (possible signs of fluid accumulation in the vascular layer of the eye (choroidal effusion) or acute angle-closure glaucoma)</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fever, sore throat, more frequent infections (agranulocytosis) These side effects are very rare or of frequency not known.</p><p dir="ltr">If you get any of these symptoms, stop taking Diozad and contact your doctor straight away (see also section 2 &ldquo;Warnings and precautions&rdquo;).</p><p dir="ltr"><strong>Side effects include:</strong></p><p dir="ltr"><strong>Uncommon (may affect up to 1 in 100 people):</strong></p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; cough, low blood pressure, light-headedness, &nbsp;&nbsp;&nbsp;&nbsp; dehydration (with symptoms of thirst, dry mouth and tongue, infrequent urination, dark colored urine, dry skin), muscle pain, tiredness, tingling or numbness, blurred vision and noises (e.g., hissing, buzzing) in ears.</p><p dir="ltr"><strong>Very rare (may affect up to 1 in 10,000 people):</strong></p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; dizziness, diarrhoea and joint pain.</p><p dir="ltr"><strong>Not known (frequency cannot be estimated from the available data):</strong></p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; breathing difficulty, severely decreased urine output, low level of sodium in the blood (which can trigger tiredness, confusion, muscle twitching and / or convulsions in severe cases), low level of potassium in the blood (sometimes with muscle weakness, muscle spasms, abnormal heart rhythm) , low level of white cells in the blood (with symptoms such as fever, skin infections, sore throat or mouth ulcers due to infections, weakness) , the level of bilirubin increased in blood (which can, in severe cases, trigger yellow skin and eyes) , the level of blood urea nitrogen and creatinine increased in blood (which can indicate abnormal kidney function) , the level of uric acid in blood increased (which can, in severe cases, trigger gout) and syncope (fainting)</p><p dir="ltr"><strong>The following side effects have been reported with products containing valsartan or hydrochlorothiazide alone:</strong></p><p dir="ltr"><strong>Valsartan</strong></p><p dir="ltr"><strong>Uncommon (may affect up to 1 in 100 people):</strong></p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; spinning sensation and &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; abdominal pain.</p><p dir="ltr"><strong>Not known (frequency cannot be estimated from the available data):</strong></p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; blistering skin (sign of dermatitis bullous).</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; skin rash with or without itching together with some of the following signs or symptoms: fever, joint pain, muscle pain, swollen lymph nodes and/or flu-like symptoms</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; rash, purplished-red spots, fever, itching (symptoms of inflammation of blood vessels)</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; low level of blood platelets (sometimes with unusual bleeding or bruising)</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; high level of potassium in the blood (sometimes with muscle spasms, abnormal heart rhythm)</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; allergic reactions (with symptoms such as rash, itching, hives, difficulty breathing or swallowing, dizziness)</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; swelling mainly of the face and throat; rash; itching</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; elevation of liver function values</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; the level of haemoglobin decreased and the percentage of red cells decreased in the blood (which both can, in severe cases, trigger an anaemia).</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; kidney failure</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; low level of sodium in the blood (which can trigger tiredness, confusion, muscle twitching and/or convulsions in severe cases)</p><p dir="ltr"><strong>Hydrochlorothiazide</strong></p><p dir="ltr"><strong>Very common (may affect more than 1 in 10 people):</strong></p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; low level of potassium in the blood</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; increase of lipids in the blood</p><p dir="ltr"><strong>Common (may affect up to 1 in 10 people):</strong></p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; low level of sodium in the blood</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; low level of magnesium in the blood</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; high level of uric acid in the blood</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; itchy rash and other types of rashes</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; reduced appetite</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; mild nausea and vomiting</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; dizziness, fainting on standing up</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inability to achieve or maintain erection</p><p dir="ltr"><strong>Rare (may affect up to 1 in 1,000 people):</strong></p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; swelling and blistering of the skin (due to increased sensitivity to sun)</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; high level of calcium in the blood</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; high level of sugar in the blood</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; sugar in the urine</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; worsening of diabetic metabolic state</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; constipation, diarrhoea, discomfort of the stomach or bowels, liver disorders which can occur together with yellow skin and eyes</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; irregular heart beat</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; headache</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; sleep disturbances</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; sad mood (depression)</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; low level of blood platelets (sometimes with bleeding or bruising underneath the skin)</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; dizziness</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; tingling or numbness</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; vision disorder</p><p dir="ltr">&nbsp;</p><p dir="ltr"><strong>Very rare (may affect up to 1 in 10,000 people):</strong></p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inflammation of blood vessels with symptoms such as rash, purplish-red spots, fever (vasculitis)</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; rash, itching, hives, difficulty breathing or swallowing, dizziness (hypersensitivity reactions)</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; facial rash, joint pain, muscle disorder, fever (lupus erythematosus)</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; severe upper stomach pain (pancreatitis)</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; difficulty breathing with fever, coughing, wheezing, breathlessness (respiratory distress including pneumonitis and pulmonary oedema)</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; pale skin, tiredness, breathlessness, dark urine (haemolytic anaemia)</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fever, sore throat or mouth ulcers due to infections (leucopenia)</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; confusion, tiredness, muscle twitching and spasm, rapid breathing (hypochloraemic alkalosis)</p><p dir="ltr"><strong>Not known (frequency cannot be estimated from the available data):</strong></p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; weakness, bruising and frequent infections (aplastic anemia)</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; severely decreased urine output (possible signs of renal disorder or renal failure)</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; rash, red skin, blistering of the lips, eyes or mouth, skin peeling, fever (possible signs of erythema multiforme)</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; muscle spasm</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fever (pyrexia)</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; weakness (asthenia)</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; skin and lip cancer (non-melanoma skin cancer)</p><p dir="ltr"><strong>Reporting of side effects</strong></p><p dir="ltr">If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly (see details below. By reporting side effects , &nbsp;you can help provide more information on the safety of this medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Keep this medicine out of the sight and reach of children.</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not use this medicine after the expiry date which is stated on the carton. The expiry date refers to the last day of that month.</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not store above 30&ordm;C. Store in the original package in order to protect from moisture.</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not use this medicine if you notice that the pack is damaged or shows signs of tampering.</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p><p dir="ltr">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">Diozad Tablet contains</p><p dir="ltr">The active ingredient is Valsartan and Hydrochlorothiazide.</p><p dir="ltr">The other ingredients are:</p><p dir="ltr">Microcrystalline Cellulose, Crospovidone, Colloidal silicon dioxide, Magnesium stearate, Opadry Pink (80/12.5 mg and 320/12.5 mg), Opadry Brown (160/12.5 mg, 160/25 mg), Opadry Yellow (320/25) and Purified water.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                80/12.5 mg: Light orange, oval shaped, biconvex, film coated tablets debossed with “L16” on one side and plain on other side.
160/12.5 mg: Dark red, oval shaped, biconvex, film-coated tablets debossed with “L17” on one side and plain on other side.
160/25 mg: Brown orange, oval shaped, biconvex, film coated tablets debossed with “L 18” on one side and plain on other side.
320/12.5 mg: Pink, oval shaped biconvex film coated tablets debossed with “L19” on side and plain on other side.
320/25 mg: Yellow, oval shaped biconvex film coated tablets debossed with “L20” on side and plain on other side.
Diozad Tablet will be packed in,
30 tablets packed in AluAlu Blister
This Leaflet was last approved in 3/2021 Version No.2
National pharmacovigilance Center Contact information:
Vigilance and Crisis Management Executive Directorate Call Center : 19999
Fax:+966-11-2057662
Mail: Vigilance and Crisis Management Executive Directorate Saudi Food and Drug Authority-Drug sector
3292 Northern Ring Road ALNafal district
Riyadh 13312 – 2688 Kingdom of Saudi Arabia
E-mail: npc.drug@sfda.gov.sa

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Manufacturer</strong><br />Macleods Pharmaceuticals Ltd<br />Plot No. 25 - 27,<br />Sr. No. 366,<br />Premier Ind. Estate,<br />Kachigam, Daman (U,T),<br />India<br />Tel: +91-0260 2244337<br />Fax: +91-0260 2241565</p><p><strong>Marketing Authorization Holder</strong></p><p>Razi Al Madina Pharamceuticals&nbsp;</p><p>Industrial City St.48&nbsp;</p><p>Al Madina Almunawarrah, Medina&nbsp;</p><p>mail : info@razial-madina.com</p><p>Tel : 009661486907211<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                03/2021
Version 2 
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">- مجموعة الدواء العلاجية يحتوي دواء دايوزادعلى مناهض لمستقبل الأنجيوتنسين -2 ومدر للبول، وهو ما يساعد على التحكم بضغط الدم المرتفع.</p><p dir="RTL">- دواعي الاستعمال العلاجية:</p><p dir="RTL">&nbsp;يستخدم دواء دايوزاد لعلاج ارتفاع ضغط الدم. يزيد ارتفاع ضغط الدم من عبء العمل على القلب والشرايين. إذا استمر ارتفاع ضغط الدم لفترة طويلة، فقد يلحق ضررا بالأوعية الدموية بالمخ والقلب والكلى ، وقد يؤدي إلى الإصابة بسكتة دماغية ، أو بفشل القلب ، أو بالفشل الكلوي . يزيد ارتفاع ضغط الدم من خطر حدوث النوبات القلبية. إن خفض ضغط دمك ليصل إلى المعدل الطبيعي يقلل من خطر الإصابة بهذه الاضطرابات.</p><p dir="RTL">&nbsp;- كيفية عمل دواء دايوزاد:</p><p>الأنجيوتنسين -2 هي مادة طبيعية موجودة في الجسم مهمتها إحداث انقباض بالأوعية الدموية، وهو ما يؤدي إلى ارتفاع ضغط الدم لديك. تمنع مادة فالسارتان الموجودة في دواء دايوزاد تأثير الأنجيوتنسين -2 . نتيجة لذلك، ترتخي الأوعية الدموية وينخفض ضغط الدم. وتقلل مدرات البول كمية الملح والماء بالجسم عن طريق زيادة تدفق البول. مع الاستخدام الفترة أطول يساعد ذلك في خفض ضغط الدم والتحكم به. إذا كانت لديك أية أسئلة حول كيفية عمل دواء دايوزاد أو لماذا تم وصف هذا الدواء لك، فاستشر طبيبك</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">لا يمكنك تناول دواء دايوزاد إلا بعد إجراء فحص طبي. قد لا يكون دواء دايوزاد مناسب لجميع المرضى. اتبع تعليمات طبيبك بعناية؛ فقد تختلف عن المعلومات العامة الواردة في هذه النشرة.</p><p dir="RTL"><strong>&nbsp;موانع استعمال دواء دايوزاد</strong></p><p dir="RTL">&bull; إذا كنت تعاني من حساسية ( فرط الحساسية ) تجاه فالسارتان أو هيدروكلوروثيازيد أو مشتقات السلفونامید ( مواد ذات صلة بهيدروكلوروثيازيد من الناحية الكيميائية )أو أي من المكونات الأخرى بهذا الدواء المدرجة في قسم 6.</p><p dir="RTL">&bull; إذا تجاوز حملك الشهر الثالث (من الأفضل أيضا تجنب تناول دواء دايوزاد في مراحل الحمل المبكرة - انظري قسم: &quot; الحمل).</p><p dir="RTL">&bull; إذا كنت تعاني من مرض شديد بالكبد، تلف القنوات الصفراوية الصغيرة داخل الكبد تليف القنوات المرارية) مما يؤدي إلى تراكم الصفراء في الكبد (الركود الصفراوي).</p><p dir="RTL">&bull; إذا كنت تعاني من مرض كلوي شديد.</p><p dir="RTL">&bull; إذا لم تكن قادرا على التبول (انقطاع البول).</p><p dir="RTL">&nbsp;&bull; إذا كنت تعالج بكلية اصطناعية.</p><p dir="RTL">&bull; إذا كان مستوى البوتاسيوم أو الصوديوم في دمك أقل من الطبيعي، أو إذا كان مستوى الكالسيوم في دمك أعلى من الطبيعي على الرغم من تلقي العلاج.</p><p dir="RTL">&bull; إذا كنت مصابا بالنقرس.</p><p dir="RTL">&bull; إذا كنت مصابا بمرض السكري أو بقصور بوظائف الكلى وتخضع للعلاج بدواء خافض لضغط الدم يحتوي على اليسكيرين.</p><p dir="RTL">إذا انطبق عليك أي من الوارد أعلاه، فأخبر طبيبك ولا تتناول دواء دايوزاد.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الاحتياطات عند استعمال دواءدايوزاد</strong></p><p dir="RTL">&bull; إذا كنت تتناول الأدوية الموفرة للبوتاسيوم أو مكملات البوتاسيوم أو بدائل الملح التي تحتوي على البوتاسيوم أو العقاقير الأخرى التي قد تسبب زيادة مستويات البوتاسيوم، قد يقوم طبيبك بالتحقق من كمية البوتاسيوم الموجودة في دمك بصفة دورية.</p><p dir="RTL">&bull; إذا كان لديك مستويات منخفضة من البوتاسيوم في دمك.</p><p dir="RTL">&bull; إذا كنت تعاني من قيء أو إسهال</p><p dir="RTL">&bull; إذا كنت تتناول جرعات مرتفعة من أحد مدرات البول (أقراص الماء).</p><p dir="RTL">&bull; إذا كنت تعاني من فشل القلب</p><p dir="RTL">&bull; إذا كنت قد تعرضت لنوبة قلبية. اتبع تعليمات طبيبك بعناية فيما يخص جرعة البدء. قد يجري طبيبك أيضا فحصا لوظائف الكلى لديك.</p><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &bull; إذا كنت تعاني من تضيق في شريان الكلى.</p><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &bull; إذا كنت قد تلقيت مؤخرًا كلية جديدة.</p><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &bull; إذا كنت تعاني من فرط الألدوستيرونية.&nbsp;هذا مرض ينتج عن أن الغدد الكظرية تقوم بإفراز كمية كبيرة هرمون الألدوستيرون.&nbsp;إذا كان هذا ينطبق عليك، فإنه لا ينصح&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;باستخدام دايوزاد</p><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &bull; إذا كنت تعاني من أمراض الكبد أو الكلى.</p><p dir="RTL">&nbsp;&bull; إذا عانيت من أي وقت مضى من تورم في اللسان والوجه ناجم عن رد فعل تحسسي يسمى الوذمة الوعائية عند تناول دواء آخر (بما في ذلك مثبطات الإنزيم المحول &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;للأنجيوتنسين) ، أخبر طبيبك عن هذه الأعراض عند تناول دايوزاد ، توقف عن تناول دايوزاد على الفور.&nbsp;انظر أيضًا القسم 4 ، &quot;الآثار الجانبية المحتملة&quot;.</p><p dir="RTL">&bull; إذا كنت تعاني من الحمى والطفح الجلدي وآلام المفاصل، والتي قد تكون علامات على (الذئبة الحمامية الجهازية (SLE،وهو ما يسمى بمرض المناعة الذاتية</p><p dir="RTL">&nbsp; &bull; إذا كنت تعاني من مرض السكري أو النقرس أو ارتفاع مستويات الكوليسترول أو الدهون الثلاثية في الدم.</p><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &bull; إذا كان لديك ردود فعل تحسسية مع استخدام أدوية أخرى لخفض ضغط الدم خاصة من مجموعة (مضادات مستقبلات الأنجيوتنسين 2) أو إذا كنت تعاني من الحساسية أو من الربو.</p><p dir="RTL">&nbsp;&bull; إذا كنت تعاني من قصور في الرؤية أو ألم في العين. يمكن أن تكون هذه أعراض ناتجة عن تجمع السائل في الطبقة الوعائية للعين (الانصباب المشيمي) أو زيادة ضغط العين</p><p dir="RTL">&nbsp; ويمكن أن يحدث في غضون ساعات إلى أسابيع من تناول دايوزاد. قد يؤدي إلى فقدان دائم للبصر إذا لم يتم علاجه. إذا كان لديك في وقت سابق حساسية من البنسلين أو السلفوناميد ، قد تكون اكثر عرضة لظهور وتطور هذه الأعراض.</p><p dir="RTL">&bull; إذا كنت تتناول أي من الأدوية التالية المستخدمة لعلاج ارتفاع ضغط الدم:&nbsp;</p><p dir="RTL">&nbsp; o&nbsp; &nbsp;مثبطات ACE مثل إنالابريل، ليسينوبريل، راميبريل)، ولا سيما إذا كان لديك مشاكل الكلى المرتبطة بالسكري.</p><p dir="RTL">&nbsp; o اليسكيرين</p><p dir="RTL">&bull; إذا كنت قد أصبت بسرطان الجلد أو إذا أصبت بآفة جلدية غير متوقعة أثناء العلاج. قد يؤدي العلاج بهيدروكلوروثيازيد ، وخاصة الاستخدام طويل الأمد بجرعات عالية ، إلى زيادة احتمالية الإصابة ببعض أنواع سرطان الجلد والشفتين (سرطان الجلد غير الميلانيني).&nbsp;احمِ بشرتك من أشعة الشمس</p><p dir="RTL">والتعرض الى االأشعة فوق البنفسجية أثناء تناول دايوزاد.</p><p dir="RTL">&nbsp;</p><p dir="RTL">قد يفحص طبيبك وظائف الكلى وضغط الدم وكمية الشوارد (على سبيل المثال البوتاسيوم) في الدم على فترات منتظمة.</p><p dir="RTL">&nbsp;</p><p dir="RTL">انظر أيضًا المعلومات الواردة تحت عنوان &quot;لا تأخذ دايوزاد&quot; قد يتسبب دايوزاد في زيادة حساسية الجلد للشمس.</p><p dir="RTL">&nbsp;</p><p dir="RTL">لا ينصح باستخدام دايوزاد في الأطفال والمراهقين (أقل من 18 عامًا).</p><p dir="RTL">&nbsp;</p><p dir="RTL">يجب أن تخبر طبيبك إذا كنت تعتقدين أنك (أو قد تصبحين) حاملاً.&nbsp; كذلك لا ينصح باستخدام دايوزاد في فترة الحمل الأولى ، ويجب عدم تناوله إذا كنت حاملاً أكثر من 3 أشهر ، لأنه قد يسبب ضررًا خطيرًا لطفلك إذا تم استخدامه في تلك المرحلة (انظر المعلومات الواردة في قسم الحمل).</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>أدوية أخرى دايوزاد</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">أخبر طبيبك أو الصيدلي إذا كنت تتناول، أو تناولت مؤخرًا أو قد تتناول أي أدوية أخرى.</p><p dir="RTL">يمكن أن تتأثر فاعلية الدواء إذا تم تناول دايوزاد مع بعض الأدوية الأخرى ، قد يكون من الضروري تغيير الجرعة أو اتخاذ احتياطات أخرى أو التوقف في بعض الحالات عن تناول أحد الأدوية.&nbsp;هذا ينطبق بشكل خاص على الأدوية التالية:</p><p dir="RTL">&bull; الليثيوم وهو دواء يستخدم لعلاج بعض حالات الأمراض النفسية.</p><p dir="RTL">&bull; الأدوية أو المواد التي قد تزيد من كمية البوتاسيوم في الدم.&nbsp;وتشمل مكملات البوتاسيوم أو بدائل الملح التي تحتوي على البوتاسيوم والأدوية التي تحافظ على البوتاسيوم والهيبارين.</p><p dir="RTL">&bull; الأدوية التي قد تقلل من كمية البوتاسيوم في الدم مثل مدرات البول (أقراص الماء) ، الكورتيكوستيرويدات ، أدوية مسهلة ، كاربينوكسولون ، أمفوتريسين أو بنسلين ج.</p><p dir="RTL">&bull; بعض المضادات الحيوية (مجموعة ريفاميسين) ، وهو دواء يستخدم للحماية من رفض الزرع (سيكلوسبورين) أو الأدوية المضادة للفيروسات والتي تستخدم لعلاج عدوى فيروس نقص المناعة البشرية / الإيدز (ريتونافير).&nbsp;هذه الأدوية قد يزيد من تأثير دايوزاد.</p><p dir="RTL">&bull; الأدوية التي قد تسبب &quot;torsades de pointes (عدم انتظام ضربات القلب) ، مثل مضادات اضطراب نبضات القلب (الأدوية المستخدمة لعلاج مشاكل القلب) وبعض مضادات الذهان.</p><p dir="RTL">&bull; الأدوية التي قد تقلل من كمية الصوديوم في الدم مثل مضادات الاكتئاب ، مضادات الذهان ومضادات الصرع.</p><p dir="RTL">&bull; أدوية لعلاج النقرس مثل ألوبيورينول ، بروبينيسيد ، سلفينبيرازون.</p><p dir="RTL">&bull; فيتامين د العلاجي ومكملات الكالسيوم.</p><p dir="RTL">&bull; أدوية لعلاج مرض السكري (التي تأخذ عن طريق الفم مثل ميتفورمين أو إنسولين).</p><p dir="RTL">&bull; أدوية أخرى لعلاج ارتفاع ضغط الدم بما في ذلك ميثيل دوبا ومثبطات الإنزيم المحول للأنجيوتنسين (مثل إنالابريل ، ليزينوبريل ، وما إلى ذلك) أو أليسكيرين (انظر أيضًا المعلومات الواردة تحت العناوين &quot;لا تأخذ دايوزاد &nbsp;و التحذيرات والاحتياطات.</p><p dir="RTL">&bull; أدوية ترفع ضغط الدم ، مثل النورأدرينالين أو الأدرينالين.</p><p dir="RTL">&bull; الديجوكسين أو جليكوسيدات الديجيتاليز الأخرى (الأدوية المستخدمة لعلاج مشاكل القلب).</p><p dir="RTL">&bull; الأدوية التي قد تزيد من مستويات السكر في الدم ، مثل ديازوكسيد أو مضادات بيتا.</p><p dir="RTL">&bull; الأدوية السيتوتوكسين (المستخدمة لعلاج السرطان) ، مثل ميثوتريكسات أو سيكلوفوسفاميد.</p><p dir="RTL">&bull; مسكنات الألم مثل مضادات الالتهاب غير الستيرويدية (NSAIDs) ، بما في ذلك الانتقائية مثبطات انزيمات الأكسدة الحلقية -2 (مثبطات Cox-2 وحمض أسيتيل الساليسيليك&gt; 3 جم.</p><p dir="RTL">&bull; أدوية إرخاء العضلات ، مثل توبوكورارين.</p><p dir="RTL">&bull; الأدوية المضادة للكولينيرجيك (الأدوية المستخدمة لعلاج مجموعة متنوعة من الاضطرابات مثل تشنجات الجهاز الهضميى، تشنج في المثانة ، ربو ، دوار الحركة ، تشنجات عضلية ، مرض باركنسون وكمساعدة في التخدير).</p><p dir="RTL">&bull; أمانتادين (دواء يستخدم لعلاج مرض باركنسون ويستخدم أيضًا لعلاج أو منع بعض الأمراض التي تسببها الفيروسات).</p><p dir="RTL">&bull; كوليسترامين وكوليستيبول (أدوية تستخدم بشكل رئيسي لعلاج المستويات العالية من الدهون في الدم).</p><p dir="RTL">&bull; &nbsp;السيكلوسبورين ، وهو دواء يستخدم في زراعة الأعضاء لتجنب رفض العضو المزروع.</p><p dir="RTL">&nbsp;&bull; الكحول والحبوب المنومة والمخدرة (الأدوية التي لها تأثير منوم أو مسكن للألم تستخدم أثناء الجراحة).</p><p dir="RTL">&bull; العوامل المستخدمة في فحوصات التصوير والمحتوية على اليود.</p><p dir="RTL"><strong>تناول</strong><strong> </strong><strong>دايوزاد</strong><strong> </strong><strong>مع الطعام والشراب والكحول</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">تجنب تناول الكحول حتى تتحدث مع طبيبك.&nbsp;قد يتسبب الكحول في انخفاض ضغط الدم أكثر و / أو تزيد من خطر إصابتك بالدوار أو الشعور بالإغماء.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الحمل والرضاعة الطبيعية</strong></p><p dir="RTL"><strong>&nbsp;</strong>&bull; يجب عليك إخبار طبيبك إذا كنت تعتقدين أنك حامل (أو قد تصبحين حاملا) سينصحك طبيبك عادة بالتوقف عن تناول دواء دايوزاد قبل أن تصبحي حاملا، أو بمجرد أن تعلمي أنك حامل، وسينصحك بتناول دواء آخر بدلا من دواء دايوزاد. لا يوصى باستخدام دواء دايوزاد في مراحل الحمل المبكرة، ويجب ألا يتم تناوله إذا تجاوز حملك الشهر الثالث؛ حيث إنه قد يسبب أضرارا خطيرة لطفلك إذا تم استخدامه بعد الشهر الثالث من الحمل.</p><p dir="RTL">لابد من اعلام طبيبك إذا كنت مرضعا، أو إذا كنت على وشك البدء في ممارسة الرضاعة الطبيعية ،لا يوصى باستخدام دواء دايوزاد من قبل الأمهات المرضعات، وقد يختار لك طبيبك دواء آخر إذا كنت ترغبين في الإرضاع، خاصة إذا كان طفلك حديث الولادة، أو مبسترا.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>القيادة واستخدام الآلات</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">&nbsp;قبل أن تقوم بقيادة مركبة أو استخدام أدوات أو تشغيل آلات أو قبل أن تقوم بعمل يتطلب تركيزا، تأكد من معرفة تأثير دواء دايوزاد عليك. مثله مثل العديد من الأدوية الأخرى التي تستخدم لعلاج ارتفاع ضغط الدم، قد يسبب دواء دايوزاد أحيانا أثناء القيادة واستخدام الآلات دوخة وقد يؤثر في القدرة على التركيز.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>3. طريقة استخدام دواء دايوزاد</strong></p><p dir="RTL">&nbsp;تناول دائما دواء دايوزاد كما أخبرك طبيبك أو مقدم الرعاية الصحية الخاص بك بالضبط.</p><p dir="RTL">يجب مراجعة طبيبك أو مقدم الرعاية الصحية أو الصيدلي الخاص بك إذا لم تكن متأكدا من كيفية الاستخدام.</p><p dir="RTL">لا يلاحظ الأشخاص المصابون بارتفاع ضغط الدم غالبا أي علامات لهذه المشكلة. وكثيرون منهم قد لا يشكون من أي شيء. ولهذا السبب، يعتبر حفاظك على مواعيدك مع طبيبك غاية في الأهمية حتى إذا كنت تشعر بأنك على ما يرام. سيخبرك طبيبك بالضبط بعدد الأقراص التي ستتناولها من دواء دايوزاد. قد يصف لك طبيبك جرعة أعلى أو أقل، وفقا لكيفية استجابتك للعلاج. الجرعة الموصى بها من دواء دايوزاد هي قرص واحد يوما.</p><p dir="RTL">لا يتم تغير الجرعة أو توقف تناول الأقراص بدون استشارة طبيبك.</p><p dir="RTL">يجب تناول الدواء في الوقت نفسه من كل يوم، عادة في الصباح.</p><p dir="RTL">يمكنك تناول دواء دايوزاد مع الطعام أو دونه.</p><p dir="RTL">يأخذ القرص مع كوب من الماء.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الجرعة الزائدة من دواء دايوزاد</strong></p><p dir="RTL">إذا تعرضت لدوخة شديدة و / أو إغماء، فاستلق واتصل بطبيبك فورا.</p><p dir="RTL">&nbsp;إذا تناولت كمية أكبر من اللازم من الأقراص بطريق الخطأ، فاتصل بطبيبك أو الصيدلي الخاص بك أو المستشفى.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نسيان تناول جرعة من دواء دايوزاد &nbsp;</strong></p><p dir="RTL">إذا نسيت تناول إحدى الجرعات ، فتناولها بمجرد تذكرك لها . وفي حال إذا كان موعد الجرعة التالية قد اقترب فتجاوز الجرعة التي نسيتها. لا تتناول جرعة مضاعفة لتعويض جرعة أغفلتها.</p><p dir="RTL"><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التوقف عن تناول دواءدايوزاد</strong></p><p dir="RTL">قد يؤدي إيقاف علاجك بدواء دايوزاد إلى تفاقم ارتفاع ضغط الدم لديك. لا تتوقف عن تناول دوائك ما لم يخبرك طبيبك بذلك.</p><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كانت لديك أية أسئلة إضافية حول استخدام هذا الدواء فاستشير طبيبك أو الصيدلي الخاص بك.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">دايوزاد مثله مثل كافة الأدوية، قد يسبب هذا الدواء أعراضا جانبية، على الرغم من عدم حدوثها لدى الجميع.</p><p dir="RTL">&nbsp;بعض الأعراض الجانبية قد تكون خطيرة وتحتاج إلى عناية طبية فورية.</p><p dir="RTL">&nbsp;عليك رؤية طبيبك فورا إذا تعرضت لأعراض الوذمة الوعائية مثل:</p><p dir="RTL">&bull; تورم الوجه أو اللسان أو البلعوم.</p><p dir="RTL">&bull; صعوبة في البلع.</p><p dir="RTL">&bull; شری وصعوبات في التنفس</p><p dir="RTL">&bull; مرض جلدي شديد يسبب ظهور طفح جلدي، واحمرارا بالجلد، وظهور بثور على الشفتين أو العينين أو الفم، وتقشر الجلد، وحمى (انحلال البشرة النخري التسممي)</p><p dir="RTL">&nbsp;&bull; انخفاض حدة الرؤية أو ألم في عينيك بسبب ارتفاع الضغط (علامات محتملة للإصابة بالزرق ضيق الزاوية).</p><p dir="RTL">&bull; حمى، التهاب الحلق، الإصابة بالعدوى بصورة أكثر تكرارا (ندرة خلايا المحببات).</p><p dir="RTL">هذه الأعراض الجانبية هي أعراض نادرة جدا أو معدل تكرارها غير معروف.</p><p dir="RTL">إذا أصبت بأي من هذه الأعراض، فتوقف عن تناول دواء دايوزاد واتصل بطبيبك فورا تشمل الأعراض الجانبية ما يلي (انظر أيضا قسم 2 قبل القيام بتناول دواء دايوزاد&lsquo;&lsquo;).</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp; <strong>غير شائعة (قد تؤثر على ما يصل إلى شخص واحد من بين كل 100 شخص): </strong></p><p dir="RTL">&bull; سعالا.</p><p dir="RTL">&bull; انخفاض ضغط الدم.</p><p dir="RTL">&bull; شعورا بخفة الرأس.</p><p dir="RTL">&bull; جفافا (مع أعراض تتمثل في العطش، وجفاف الفم واللسان، وندرة التبول، وبول داكن اللون، وجفاف الجلد).</p><p dir="RTL">&bull; ألما في العضلات.</p><p dir="RTL">&nbsp;&bull; تعبا.</p><p dir="RTL">&nbsp;&bull; وخا أو تنميلا .</p><p dir="RTL">&bull; عدم وضوح الرؤية.</p><p dir="RTL">&nbsp;&bull; سماع ضوضاء في الأذنين (على سبيل المثال، هسهسة أو طنين).</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>&nbsp;نادرة جدا (قد تؤثر على ما يصل إلى شخص واحد من بين كل 10000 شخص): </strong></p><p dir="RTL">&bull; دوخة.</p><p dir="RTL">&nbsp;&bull; إسهالا.</p><p dir="RTL">&bull; ألما بالمفاصل.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>غير معروفة (لا يمكن تقدير معدل التكرار من واقع البيانات المتاحة):</strong></p><p dir="RTL">&bull; صعوبة في التنفس.</p><p dir="RTL">&bull; انخفاضا شديدا في إنتاج البول.</p><p dir="RTL">&bull; انخفاض مستوى الصوديوم في الدم (وهو ما قد يؤدي إلى التعب و / أو الارتباك و / أو الانتفاض العضلي و / أو التشنجات في الحالات الشديدة).</p><p dir="RTL">&bull; انخفاض مستوى البوتاسيوم في الدم (في بعض الأحيان يكون ذلك مصحوبا بضعف عضلي أو تقلصات عضلية أو اضطراب بالنظم القلبي).</p><p dir="RTL">&bull; انخفاض مستوى خلايا الدم البيضاء (مع أعراض مثل: الحمى، أو عدوى الجلد أو التهاب الحلق أو قرح الفم بسبب العدوى، أو الضعف).</p><p dir="RTL">&bull; ارتفاع مستوى البيليروبين في الدم (وهو ما قد يؤدي في حالاته الشديدة إلى اصفرار الجلد والعينين).</p><p dir="RTL">&bull; ارتفاع مستوى نيتروجين يوريا الدم والكرياتينين في الدم (وهو ما قد يدل على اضطراب وظائف الكلى).</p><p dir="RTL">&nbsp;&bull; ارتفاع مستوى حمض اليوريك (وهو ما قد يؤدي في الحالات الشديدة إلى الإصابة بالنقرس)</p><p dir="RTL">&bull; غشيا (إغماء).</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>&nbsp;تم الإبلاغ عن الأعراض الجانبية التالية مع المنتجات التي تحتوي على فالسارتان وحده أو هيدروكلوروثيازيد وحده:</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>&nbsp;</strong><strong>فالسارتان </strong></p><p dir="RTL"><strong>غير شائعة (قد تؤثر على ما يصل إلى شخص واحد من بين كل 100 شخص): </strong></p><p dir="RTL">&bull; شعورا بالدوران.</p><p dir="RTL">&bull; الما بالبطن.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>غير معروفة (لا يمكن تقدير معدل التكرار من واقع البيانات المتاحة): </strong></p><p dir="RTL">&bull; بثورا على الجلد (علامة على الإصابة بالتهاب الجلد الفقاعي).</p><p dir="RTL">&bull; طفحا على الجلد مع أو بدون حكة جنبا إلى جنب مع بعض العلامات أو الأعراض التالية: حمى و / أو ألم بالمفاصل و / أو ألم عضلي و / أو تورم العقد الليمفاوية و / أو أعراض شبيهة بأعراض الأنفلونزا.</p><p dir="RTL">&bull; طفح جلدي، بقع حمراء مائلة إلى اللون الأرجواني، حمى، حكة (أعراض التهاب الأوعية الدموية).</p><p dir="RTL">&nbsp;&bull; انخفاض مستوى الصفائح الدموية (في بعض الأحيان يكون ذلك مصحوبا بنزيف أو كدمات غير معتادة).</p><p dir="RTL">&bull; ارتفاع مستوى البوتاسيوم في الدم (في بعض الأحيان يكون ذلك مصحوبا بتقلصات عضلية واضطراب بالنظم القلبي).</p><p dir="RTL">&nbsp;&bull; تفاعلات حساسية (مع أعراض مثل: الطفح الجلدي، أو الحكة، أو الشرى، أو صعوبة التنفس أو البلع، أو الدوخة).</p><p dir="RTL">&bull; تورم بشكل أساسي في الوجه والحلق، طفح جلدي، حكة.</p><p dir="RTL">&bull; ارتفاع قيم وظائف الكبد.</p><p dir="RTL">&bull; انخفاض مستوى الهيموجلوبين ونسبة خلايا الدم الحمراء في الدم (وكلاهما قد يؤدي - في الحالات الشديدة - إلى الإصابة بفقر الدم).</p><p dir="RTL">. فشل كلوي.</p><p dir="RTL">&bull; انخفاض مستوى الصوديوم في الدم (وهو ما قد يؤدي إلى التعب و / أو الارتباك و / أو الانتفاض العضلي و / أو التشنجات في الحالات الشديدة).</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;<strong>هیدروکلوړوثيازيد</strong><strong> </strong></p><p dir="RTL"><strong>شائعة جدا (قد تؤثر على أكثر من شخص واحد من بين كل 10 أشخاص):</strong></p><p dir="RTL">&nbsp;&bull; انخفاض مستوى البوتاسيوم في الدم.</p><p dir="RTL">&bull; ارتفاع مستوى الدهون في الدم.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>&nbsp;شائعة (قد تؤثر على ما يصل إلى شخص واحد من بين كل 10 أشخاص): </strong></p><p dir="RTL">&bull; انخفاض مستويات الصوديوم بالدم.</p><p dir="RTL">&nbsp;&bull; انخفاض مستوى الماغنسيوم في الدم.</p><p dir="RTL">&bull;ارتفاع مستوى حمض اليوريك في الدم.</p><p dir="RTL">&bull; طفح جلديا مثير للحكة وأنواع أخرى من الطفح الجلدي</p><p dir="RTL">&bull; انخفاض الشهية.</p><p dir="RTL">&bull; الغثيان الطفيف والقيء.</p><p dir="RTL">&nbsp;&bull; دوخة، إغماء عند النهوض.</p><p dir="RTL">&bull; عدم القدرة على تحقيق الانتصاب أو الوصول إليه.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>نادرة (قد تؤثر على ما يصل إلى شخص واحد من بين كل 1000 شخص):</strong></p><p dir="RTL">&nbsp;&bull; تورم الجلد وظهور بثور عليه (بسبب زيادة الحساسية لأشعة الشمس).</p><p dir="RTL">&nbsp;&bull; ارتفاع مستوى الكالسيوم في الدم</p><p dir="RTL">&nbsp;&bull; ارتفاع مستوى السكر في الدم</p><p dir="RTL">&bull; وجود سكر بالبول.</p><p dir="RTL">&nbsp;&bull; تفاقم الحالة الاستقلابية لمرض السكرى.</p><p dir="RTL">&nbsp;&bull; إمساك، إسهال، شعور غير مريح بالمعدة أو الأمعاء، اضطرابات الكبد التي قد تحدث بمصاحبة اصفرار الجلد والعينين.</p><p dir="RTL">&nbsp;&bull;عدم انتظام ضربات القلب.</p><p dir="RTL">&nbsp;&bull; الصداع</p><p dir="RTL">&nbsp;&bull; اضطرابات النوم.</p><p dir="RTL">&nbsp;&bull; حالة مزاجية حزينة (اكتئاب).</p><p dir="RTL">&nbsp;&bull; انخفاض مستوى الصفائح الدموية (في بعض الأحيان يكون ذلك مصحوبا بنزيف أو كدمات أسفل الجلد).</p><p dir="RTL">&nbsp;&bull; دوخة.</p><p dir="RTL">&nbsp;&bull; الوخز أو التنميل.</p><p dir="RTL">&nbsp;&bull;اضطراب الرؤية.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>نادرة جدا (قد تؤثر على ما يصل إلى شخص واحد من بين كل 10000 شخص):</strong></p><p dir="RTL">&nbsp;&bull; التهاب الأوعية الدموية مع أعراض مثل: الطفح الجلدي، بقع حمراء مائلة إلى اللون الأرجواني، حمى (التهاب الأوعية الدموية).</p><p dir="RTL">&nbsp;&bull; طفح جلدي، حكة، شري، صعوبة التنفس أو البلع، دوخة (تفاعلات فرط الحساسية).</p><p dir="RTL">&nbsp;&bull; طفحا جلديا بالوجه، ألام بالمفاصل، اضطرابا عضليا، حمى (الذئبة الحمامية).</p><p dir="RTL">&nbsp;&bull; ألما شديدا بأعلى المعدة (علامة على الإصابة بالتهاب البنكرياس).</p><p dir="RTL">&nbsp;&bull; صعوبة بالتنفس مع حمى، سعال، أزيز بالصدر، عسر التنفس (أزمة تنفسية بما في ذلك الالتهاب الرئوي والوذمة الرئوية).</p><p dir="RTL">&nbsp;&bull; بشرة شاحبة، تعبا، عسر التنفس، بولا داكنا (فقر الدم الانحلالي).</p><p dir="RTL">&bull; حمى، التهاب الحلق أو الإصابة بقرح في الفم بسبب العدوى (نقص كريات الدم البيضاء).</p><p dir="RTL">&bull;ارتباكا، تعبا، انتفاضا وتقلصا عضليا، معدل تنفس سريع (قلاء نقص كلوريد الدم).</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>غير معروفة (لا يمكن تقدير معدل التكرار من واقع البيانات المتاحة): </strong></p><p dir="RTL">&bull; ضعفا وكدمات وإصابة بالعدوى بشكل متكرر (فقر الدم غير التنسجي).</p><p dir="RTL">&bull; انخفاضا شديدا في إنتاج البول (علامات محتملة على الإصابة باضطراب كلوي أو فشل كلوي)</p><p dir="RTL">&bull; طفحا جلديا، احمرار الجلد، ظهور بثور على الشفتين أو العينين أو الفم، تقشر الجلد، حمى (علامات محتملة للاحمرار متعدد الأشكال)</p><p dir="RTL">&bull; تقلصات عضلية.</p><p dir="RTL">&bull; حمى (ارتفاع درجة الحرارة).</p><p dir="RTL">&bull; الضعف (الوهن)</p><p dir="RTL">&bull; سرطان الجلد والشفة (سرطان الجلد غير الميلانيني).</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&bull; يحفظ بعيدا عن متناول ورؤية الأطفال.</p><p dir="RTL">&bull; لا يستخدم دواء دايوزاد بعد انتهاء تاريخ الصلاحية الموضح على العبوة. يشير تاريخ انتهاء الصلاحية إلى اليوم الأخير من ذلك الشهر.</p><p dir="RTL">&bull; لا يخزن في درجة حرارة تتعدى 30 درجة مئوية ،&bull; تحفظ الأقراص داخل العبوة الأصلية لحمايتها من الرطوبة.</p><p dir="RTL">&bull; لا تستخدم هذا الدواء إذا لاحظت أن العبوة تالفة أو تظهر عليها علامات العبث.</p><p dir="RTL">&bull; لا تتخلص من الأدوية في مياه الصرف الصحي أو النفايات المنزلية.&nbsp;اسأل الصيدلي الخاص بك عن كيفية القيام بذلك للتخلص من الأدوية التي لم تعد تستخدمها.&nbsp;ستساعد هذه الإجراءات في حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">المواد الفعالة بدواء دايوزاد هي فالسارتان ( 80 مجم أو 160 مجم أو 320 مجم ) وهيدروكلوروثيازيد ( 12.5 مجم أو 25 مجم )</p><p dir="RTL">المكونات الأخرى هي سليلوز دقيق التبلور، ثاني أكسيد السيليكون، کروسبوفيدون، ستيرات الماغنسيوم. اوبادراي وردي (80/12.5 ملجم و 320/12.5 ملجم)، أوبادراي بني (160/12.5 ملجم و 160/25 ملجم)، أوبادراي أصفر (320/25 ملجم) ، ماء معالج</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>&nbsp;يتوفر دواء دايوزاد في هيئة أقراص مغلفة بخمسة تركيزات:</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>&nbsp;أقراص دواء دايوزاد المغلفة&nbsp; ( 80 /12.5 مجم) </strong></p><p dir="RTL">&nbsp;تحتوي على 80 مجم فالسارتان و 12.5 مجم هيدروكلوروثيازيد . هي عبارة عن أقراص مغلفة بيضاوية محدبة من الجهتين، غير قابلة للانقسام، الأقراص لونها برتقالي فاتح وعلى أحد جانبيها أحرف &rdquo; L16 &ldquo; &nbsp;ولا شيء على الجانب الآخر.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>أقراص دواء</strong><strong> </strong><strong>دايوزاد</strong><strong> </strong><strong>المغلفة ( 160 /12.5 مجم)</strong></p><p dir="RTL">&nbsp;تحتوي على 160 مجم فالسارتان و 12.5 مجم و هيدروكلوروثيازيد . هي عبارة عن أقراص مغلفة بيضاوية محدبة من الجهتين ، غير قابلة للانقسام ، الأقراص لونها أحمر داكن وعلى أحد جانبيها أحرف &rdquo; L17 &ldquo; &nbsp;ولا شيء على الجانب الآخر.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>أقراص دواء</strong><strong> </strong><strong>دايوزاد</strong><strong> </strong><strong>المغلفة ( 25/160 مجم</strong><strong>(</strong></p><p dir="RTL">&nbsp;تحتوي على 160 مجم فالسارتان ، و 25 مجم هيدروكلوروثيازيد . هي عبارة عن أقراص مغلفة بيضاوية محدبة من الجهتين ، غير قابلة للانقسام ، الأقراص لونها برتقالي مائل إلى اللون البني &nbsp;وعلى أحد جانبيها أحرف &rdquo; L18 &ldquo; &nbsp;ولا شيء على الجانب الآخر.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>&nbsp;أقراص دواء دايوزاد المغلفة ( 320 /12.5 مجم )</strong></p><p dir="RTL">&nbsp;تحتوي على 320 مجم فالسارتان و 12.5 مجم هيدروكلوروثيازيد . هي عبارة عن أقراص مغلفة بيضاوية محدبة من الجهتين ، غير قابلة للانقسام ، الأقراص لونها وردي وعلى أحد جانبيها أحرف &rdquo; L19 &ldquo; &nbsp;ولا شيء على الجانب الآخر.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>أقراص دواء</strong><strong> </strong><strong>دايوزادالمغلفة&nbsp; ( 25/320 مجم</strong><strong>(</strong><strong> </strong></p><p dir="RTL">تحتوي على 320 مجم : فالسارتان و 25 مجم هیدروکلوروثيازيد .هي عبارة عن قراص مغلفة بيضاوية محدبة من الجهتين، غير قابلة للانقسام ، الأقراص لونها أصفر وعلى أحد جانبيها أحرف &rdquo; L20 &ldquo; &nbsp;ولا شيء على الجانب الآخر.</p><p dir="RTL">&nbsp;</p><p dir="RTL">أقراص دايوزاد معبأة ۳۰ حبة داخل شريط من مادة الألومنيوم</p><p dir="RTL">&nbsp;</p><p dir="RTL">أخر مراجعه لهذه النشرة مارس 2021</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>للاتصال بالإدارة التنفيذية للتيقظ وتقييم المنافع والمخاطر</strong></p><p dir="RTL">الاتصال الموحد:</p><p dir="RTL">۱۹۹۹۹</p><p dir="RTL">۸۰۰۲۹۰۰۰۰</p><p dir="RTL">فاکس : 2057622-11-00966</p><p dir="RTL">العنوان البريدي الإدارة التنفيذية للتيقظ وإدارة الأزمات الهيئة العامة للغذاء والدواء - قطاع الدواء</p><p dir="RTL">۳۲۹۲ الطريق الدائري الشمالي - حي النفل</p><p dir="RTL">الرياض ۱۳۳۱۲ &ndash; 8862</p><p dir="RTL">المملكة العربية السعودية</p><p dir="RTL">البريد الإلكتروني&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;npc.drug@sfda.gov.sa</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p><strong><span style="text-align:unset">مالك حق التسويق&nbsp; &nbsp; &nbsp; &nbsp;</span></strong></p><p><span style="text-align:unset">&nbsp;</span>مصنع رازي المدينه للصناعات الدوائية&nbsp;</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;المملكة العربية السعودية</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;المدينة المنورة - طريق جدة</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;المدينة الصناعية</p><p>شارع 48</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;هاتف :&nbsp;00966148690721</p><p><strong>الشركة الصانعه شركة ماكليودز للأدوية المحدودة</strong></p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;قرية ثيدا، مكتب بريد لودهيماجرا،</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;بادي، حي سولان،</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;هيماشال براديش - 174101</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;الهند.</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;هاتف: 00911795661400</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;فاكس: 00911795661452</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            03/2021
الإصدار الثاني 
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Diozad 80/12.5, 160/12.5, 160/25, 320/12.5, 320/25 mg tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each film coated tablet contains:
Diozad 320/12.5 (Valsartan 320 mg & Hydrochlorothiazide 12.5 mg)
Diozad 320/25 (Valsartan 320 mg & Hydrochlorothiazide 25 mg)
Diozad 160/25 (Valsartan 160 mg & Hydrochlorothiazide 25 mg)
Diozad 160/12.5 (Valsartan 160 mg & Hydrochlorothiazide 12.5 mg)
Diozad 80/12.5 (Valsartan 80 mg & Hydrochlorothiazide 12.5 mg)
For Excipients see point 6.1
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Film-coated tablet 
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Treatment of essential hypertension in adults. Diozad is fixed-dose combination. It is indicated in patients whose blood pressure is not adequately controlled on valsartan or hydrochlorothiazide monotherapy<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The recommended dose of Diozad 80/12.5mg or 160/12.5mg is one film-coated tablet once daily. Dose titration with the individual components is recommended. In each case, up- titration of individual components to the next dose should be followed in order to reduce the risk of hypotension and other adverse events. The clinical response to Diozad should be evaluated after initiating therapy and if blood pressure remains uncontrolled, the dose may be increased by increasing either one of the components to a maximum dose of Diozad 320 mg/25 mg. The antihypertensive effect is substantially present within 2 weeks. In most patients, maximal effects are observed within 4 weeks. However, in some patients, 4-8 weeks of treatment may be required. This should be taken into account during dose-titration</p><p>Method of administration Diozad can be taken with or without food and should be administered with water</p><p>Special populations Renal impairment No dose adjustment is required for patients with mild to moderate renal impairment (Glomerular Filtration Rate (GFR) &ge; 30 ml/min). Due to the hydrochlorothiazide component, Diozad is contraindicated in patients with severe renal impairment (GFR &lt; 30 mL/min) and anuria. Hepatic impairment In patients with mild to moderate hepatic impairment without cholestasis the dose of valsartan should not exceed 80 mg. No adjustment of the hydrochlorothiazide dose is required for patients with mild to moderate hepatic impairment. Due to the valsartan component, Diozad is contraindicated in patients with severe hepatic impairment or with biliary cirrhosis and cholestasis. Older People No dose adjustment is required in elderly patients. Paediatric patients Diozad is not recommended for use in children below the age of 18 years due to a lack of data on safety and efficacy.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                • Hypersensitivity to valsartan, hydrochlorothiazide, other sulfonamide-derived
medicinal products or to any of the excipients.
• Second and third trimester of pregnancy.
• Severe hepatic impairment, biliary cirrhosis and cholestasis.
• Severe renal impairment (creatinine clearance < 30 ml/min), anuria.
• Refractory hypokalaemia, hyponatraemia, hypercalcaemia, and symptomatic
hyperuricaemia.
• Concomitant use of Diozad with aliskiren in patients with diabetes mellitus or
renal impairment (GFR < 60 mL/min/1.73m2
).
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Serum electrolyte changes Valsartan</p><p>Concomitant use with potassium supplements, potassium-sparing diuretics, salt substitutes containing potassium, or other agents that may increase potassium levels (heparin, etc.) is not recommended. Monitoring of potassium should be undertaken as appropriate. Hydrochlorothiazide Hypokalaemia may occur under treatment with thiazide diuretics, including hydrochlorothiazide. Frequent monitoring of serum potassium is recommended. Treatment with thiazide diuretics, including hydrochlorothiazide may occur with hyponatraemia and hypochloraemic alkalosis. Thiazides, including hydrochlorothiazide increase the urinary excretion of magnesium, which may result in hypomagnesaemia.Calcium excretion is decreased by thiazide diuretics. This may result in hypercalcaemia. As for any patient receiving diuretic therapy, periodic determination of serum electrolytes should be performed at appropriate intervals. Sodium, and/or volume-depleted patients Patients receiving thiazide diuretics, including hydrochlorothiazide, should be observed for clinical signs of fluid or electrolyte imbalance. In severely sodium-depleted and/or volume-depleted patients, such as those receiving high doses of diuretics, symptomatic hypotension may occur in rare cases after initiation of therapy with Diozad. Sodium and/or volume depletion should be corrected before starting treatment with Diozad. Patients with severe chronic heart failure or other conditions with stimulation of the renin-angiotensin-aldosterone-system In patients whose renal function may depend on the activity of the reninangiotensin-aldosterone system (e.g. patients with severe congestive heart failure), treatment with angiotensin converting enzyme inhibitors may occur with oliguria and/or progressive azotaemia, and in rare cases with acute renal failure and/or death. Evaluation of patients with heart failure or post-myocardial infarction should always include assessment of renal function. The use of Diozad in patients with severe chronic heart failure has not been established. Hence it cannot be excluded that because of the inhibition of the reninangiotensin-aldosterone system the application of Diozad as well may be&nbsp;associated with impairment of the renal function. Diozad should not be used in these patients. Renal artery stenosis Diozad should not be used to treat hypertension in patients with unilateral or bilateral renal artery stenosis or stenosis of the artery to a solitary kidney, since blood urea and serum creatinine may increase in such patients. Primary hyperaldosteronism Patients with primary hyperaldosteronism should not be treated with Diozad as their renin-angiotensin system is not activated. Aortic and mitral valve stenosis, hypertrophic obstructive cardiomyopathy As with all other vasodilators, special caution is indicated in patients suffering from aortic or mitral stenosis, or hypertrophic obstructive cardiomyopathy (HOCM). Renal impairment No dosage adjustment is required for patients with renal impairment with a creatinine clearance &gt; 30 ml/min. Periodic monitoring of serum potassium, creatinine and uric acid levels is recommended when Diozad is used in patients with renal impairment. Kidney transplantation There is currently no experience on the safe use of Diozad in patients who have recently undergone kidney transplantation. Hepatic impairment In patients with mild to moderate hepatic impairment without cholestasis, Diozad should be used with caution. Thiazides should be used with caution in patients with impaired hepatic function or progressive liver disease, since minor alterations of fluid and electrolyte balance may precipitate hepatic coma. History of angioedema Angioedema, including swelling of the larynx and glottis, causing airway obstruction and/or swelling of the face, lips, pharynx, and/or tongue may occur in patients treated with valsartan; some of these patients previously experienced angioedema with other drugs including ACE inhibitors. Diozad should be immediately discontinued in patients who develop angioedema, and Diozad should not be re-administered.</p><p>Systemic lupus erythematosus Thiazide diuretics, including hydrochlorothiazide, have been reported to exacerbate or activate systemic lupus erythematosus. Other metabolic disturbances Thiazide diuretics, including hydrochlorothiazide, may alter glucose tolerance and raise serum levels of cholesterol, triglycerides and uric acid. In diabetic patients dosage adjustments of insulin or oral hypoglycaemic agents may be required. Thiazides may reduce urinary calcium excretion and cause an intermittent and slight elevation of serum calcium in the absence of known disorders of calcium metabolism.Marked hypercalcaemia may be evidence of underlying hyperparathyroidism. Thiazides should be discontinued before carrying out tests for parathyroid function. Photosensitivity Cases of photosensitivity reactions have been reported with thiazides diuretics. If photosensitivity reaction occurs during treatment, it is recommended to stop the treatment. If a re-administration of the diuretic is deemed necessary, it is recommended to protect exposed areas to the sun or to artificial UVA. Pregnancy Angiotensin II Receptor Antagonists (AIIRAs) should not be initiated during pregnancy. Unless continued AIIRAs therapy is considered essential, patients planning pregnancy should be changed to alternative anti-hypertensive treatments which have an established safety profile for use in pregnancy. When pregnancy is diagnosed, treatment with AIIRAs should be stopped immediately, and, if appropriate, alternative therapy should be started . General Caution should be exercised in patients who have shown prior hypersensitivity to other angiotensin II receptor antagonists. Hypersensitivity reactions to hydrochlorothiazide are more likely in patients with allergy and asthma. Acute Angle-Closure Glaucoma Hydrochlorothiazide, a sulfonamide, may occur with an idiosyncratic reaction resulting in acute transient myopia and acute angle-closure glaucoma. Symptoms include acute onset of decreased visual acuity or ocular pain and typically occur&nbsp;within hours to week of a drug initiation. Untreated acute-angle closure glaucoma can lead to permanent vision loss. The primary treatment is to discontinue hydrochlorothiazide as rapidly as possible. Prompt medical or surgical treatment may need to be considered if the intraocular pressure remains uncontrolled. Risk factors for developing acute angle closure glaucoma may include a history of sulfonamide or penicillin allergy. Dual Blockade of the Renin-Angiotensin-Aldosterone System (RAAS) The concomitant use of ACE inhibitors, angiotensin II receptor blockers or aliskiren increases the risk of hypotension, hyperkalaemia, and decreased renal function (including acute renal failure). Dual blockade of the RAAS through the combined use of ACE inhibitors, angiotensin II receptor blockers or aliskiren is therefore not recommended. If dual blockade therapy is considered absolutely necessary, this should only occur under specialist supervision and subject to frequent close monitoring of renal function, electrolytes and blood pressure. ACE inhibitors and angiotensin II receptor blockers should not be used concomitantly in patients with diabetic nephropathy</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Interactions related to both Diozad Concomitant use not recommended Lithium Reversible increases in serum lithium concentrations and toxicity have been reported during concurrent use of ACE inhibitors and thiazide, including hydrochlorothiazide. Due to the lack of experience with concomitant use of valsartan and lithium, this combination is not recommended. If the combination proves necessary, careful monitoring of serum lithium levels is recommended. Concomitant use requiring caution Other antihypertensive agents Diozad may increase the effects of other agents with antihypertensive properties (e.g. guanethidine, methyldopa, vasodilators, ACEI, ARBs, beta-blockers, calcium channel blockers and DRIs).</p><p>Pressor amines (e.g. noradrenaline, adrenaline) Possible decreased response to pressor amines. The clinical significance of this effect is uncertain and not sufficient to preclude their use. Non-steroidal anti-inflammatory medicines (NSAIDs), including selective COX-2 inhibitors, acetylsalicylic acid (&gt;3 g/day), and non-selective NSAIDs NSAIDS can attenuate the antihypertensive effect of both angiotensin II antagonists and hydrochlorothiazide when administered simultaneously. Furthermore, concomitant use of Diozad and NSAIDs may lead to worsening of renal function and an increase in serum potassium. Therefore, monitoring of renal function at the beginning of the treatment is recommended, as well as adequate hydration of the patient. Interactions related to valsartan Dual blockade of the Renin-Angiotensin-System (RAS) with ARBs, ACEIs, or aliskiren Dual blockade of the renin-angiotensin-aldosterone-system (RAAS) through the combined use of ACE inhibitors, angiotensin II receptor blockers or aliskiren is associated with a higher frequency of adverse events such as hypotension, hyperkalaemia and decreased renal function (including acute renal failure) compared to the use of s single RAAS-acting agent. Concomitant use not recommended Potassium-sparing diuretics, potassium supplements, salt substitutes containing potassium and other substances that may increase potassium levels If a medicinal product that affects potassium levels is considered necessary in combination with valsartan, monitoring of potassium plasma levels is advised. Transporters In vitro data indicates that valsartan is a substrate of the hepatic uptake transporter OATP1B1/OATP1B3 and the hepatic efflux transporter MRP2. The clinical relevance of this finding is unknown. Co-administration of inhibitors of the uptake transporter (eg. rifampin, ciclosporin) or efflux transporter (eg. ritonavir) may increase the systemic exposure to valsartan. Exercise appropriate care when initiating or ending concomitant treatment with such drugs. No interaction&nbsp;In drug interaction studies with valsartan, no interactions of clinical significance have been found with valsartan or any of the following substances: cimetidine, warfarin, furosemide, digoxin, atenolol, indomethacin, hydrochlorothiazide, amlodipine, glibenclamide. Digoxin and indomethacin could interact with the hydrochlorothiazide component of Valsartan . Interactions related to hydrochlorothiazide Concomitant use requiring caution Medicinal products affecting serum potassium level The hypokalaemic effect of hydrochlorothiazide may be increased by concomitant administration of kaliuretic diuretics, corticosteroids, laxatives, ACTH, amphotericin, carbenoxolone, penicillin G, salicylic acid and derivatives. If these medicinal products are to be prescribed with the hydrochlorothiazidevalsartan combination, monitoring of potassium plasma levels is advised. Medicinal products that could induce torsades de pointes Due to the risk of hypokalaemia, hydrochlorothiazide should be administered with caution when associated with medicinal products that could induce torsades de pointes, in particular Class Ia and Class III antiarrhythmics and some antipsychotics. Medicinal products affecting serum sodium level The hyponatraemic effect of diuretics may be intensified by concomitant administration of drugs such as antidepressants, antipsychotics, antiepileptics, etc. Caution is advised in long-term administration of these drugs. Digitalis glycosides Thiazide-induced hypokalaemia or hypomagnesaemia may occur as undesirable effects favouring the onset of digitalis-induced cardiac arrhythmias. Calcium salts and vitamin D Administration of thiazide diuretics, including hydrochlorothiazide, with vitamin D or with calcium salts may potentiate the rise in serum calcium. Concomitant use of thiazide type diuretics with calcium salts may cause hypercalcaemia in patients pre-disposed for hypercalcaemia (e.g. hyperparathyroidism, malignancy or vitamin-D-mediated conditions) by increasing tubular calcium reabsorption. Antidiabetic agents (oral agents and insulin)&nbsp;Thiazides may alter glucose tolerance. Dose adjustment of the antidiabetic medicinal product may be necessary. Metformin should be used with caution because of the risk of lactic acidosis induced by possible functional renal failure linked to hydrochlorothiazide. Beta blockers and diazoxide Concomitant use of thiazide diuretics, including hydrochlorothiazide, with beta blockers may increase the risk of hyperglycaemia. Thiazide diuretics, including hydrochlorothiazide, may enhance the hyperglycaemic effect of diazoxide. Medicinal products used in the treatment of gout (probenecid, sulfinpyrazone and allopurinol) Dose adjustment of uricosuric medications may be necessary as hydrochlorothiazide may raise the level of serum uric acid. Increase of dosage of probenecid or sulfinpyrazone may be necessary. Co-administration of thiazide diuretics, including hydrochlorothiazide, may increase the incidence of hypersensitivity reactions to allopurinol. Anticholinergic agents and other medicinal products affecting gastric motility The bioavailability of thiazide-type diuretics may be increased by anticholinergic agents (e.g. atropine, biperiden), apparently due to a decrease in gastrointestinal motility and the stomach emptying rate. Conversely, it is anticipated that prokinetic drugs such as cisapride may decrease the bioavailability of thiazidetype diuretics. Amantadine Thiazides, including hydrochlorothiazide, may increase the risk of adverse effects caused by amantadine. Ion exchange resins Absorption of thiazide diuretics, including hydrochlorothiazide, is decreased by cholestyramine or colestipol. This could result in sub-therapeutic effects of thiazide diuretics. However, staggering the dosage of hydrochlorothiazide and resin such that hydrochlorothiazide is administered at least 4 h before or 4-6 h after the administration of resins would potentially minimise the interaction. Cytotoxic agents&nbsp;</p><p>Thiazides, including hydrochlorothiazide, may reduce renal excretion of cytotoxic agents (e.g. cyclophosamide, methotrexate) and potentiate their myelosuppressive effects. Non-depolarising skeletal muscle relaxants (e.g. tubocurarine) Thiazides, including hydrochlorothiazide, potentiate the action of skeletal muscle relaxants such as curare derivatives. Ciclosporin Concomitant treatment with ciclosporin may increase the risk of hyperuricaemia and gout-type complications. Alcohol, barbiturates or narcotics Concomitant administration of thiazide diuretics with substances that also have a blood pressure lowering effect (e.g. by reducing sympathetic central nervous system activity or direct vasodilatation activity) may potentiate orthostatic hypotension. Methyldopa There have been isolated reports of haemolytic anaemia in patients receiving concomitant treatment with methyldopa and hydrochlorothiazide. Iodine contrast media In case of diuretic-induced dehydration, there is an increased risk of acute renal failure, especially with high doses of the iodine product. Patients should be rehydrated before the administration.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy: Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death. Resulting oligohydramnios can be associated with fetal lung hypoplasia and skeletal deformations. Potential neonatal adverse effects include skull hypoplasia, anuria, hypotension, renal failure, and death. When pregnancy is detected, discontinue Diozad as soon as possible. These adverse outcomes are usually associated with use of these drugs in the second and third trimester of pregnancy. Most epidemiologic studies examining fetal abnormalities after exposure to antihypertensive use in the first trimester have not distinguished drugs affecting the renin-angiotensin system from other antihypertensive agents. Appropriate management of maternal hypertension during pregnancy is important to optimize outcomes for both mother and fetus. In the unusual case that there is no appropriate alternative to therapy with drugs affecting the renin-angiotensin system for a particular patient, apprise the mother of the potential risk to the fetus. Perform serial ultrasound examinations to assess the intra-amniotic environment. If oligohydramnios is observed, discontinue Diozad, unless it is considered lifesaving for the mother. Fetal testing may be appropriate, based on the week of pregnancy. Patients and physicians should be aware, however, that oligohydramnios may not appear until after the fetus has sustained irreversible injury. Closely observe infants with histories of in utero exposure to Diozad for hypotension, oliguria, and hyperkalemia. Hydrochlorothiazide Thiazides can cross the placenta, and concentrations reached in the umbilical vein approach those in the maternal plasma. Hydrochlorothiazide, like other diuretics, can cause placental hypoperfusion. It accumulates in theamniotic fluid, with reported concentrations up to 19 times higher than in umbilical vein plasma. Use of thiazides during pregnancy is associated with a risk of fetal or neonatal jaundice or thrombocytopenia. Since they do not prevent or alter the course of EPH (Edema, Proteinuria, Hypertension) gestosis (pre-eclampsia), these drugs should not be used to treat hypertension in pregnant women. The use of hydrochlorothiazide for other indications (e.g. heart disease) in pregnancy should be avoided. Lactation: It is not known whether valsartan is excreted in human milk. Valsartan was excreted into the milk of lactating rats; however, animal breast milk drug levels may not accurately reflect human breast milk levels. Hydrochlorothiazide is excreted in human breast milk. Because many drugs are excreted into human milk and because of the potential for adverse reactions in nursing infants from Diozad, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No studies on the effect of Diozad, on the ability to drive and use machines have been performed. When driving vehicles or operating machines it should be taken into account that occasionally dizziness or weariness may occur.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The following listing of undesirable effects is classified as: very common (&gt;1/10); common (&gt;1/100, 1/1,000, 1/10,000, &lt;1/1,000); very rare (&lt;1/10,000), including isolated cases.&nbsp;</p><p>Frequency of adverse reactions with valsartan/hydrochlorothiazide</p><p>&nbsp;</p><p>- <strong>Metabolism and nutrition disorders :</strong> Uncommon Dehydration&nbsp;</p><p><strong>- Nervous system disorders</strong>&nbsp;:&nbsp;</p><p>Very rare Dizziness,&nbsp;&nbsp;</p><p>Uncommon Paraesthesia ,&nbsp;</p><p>Not known Syncope&nbsp;</p><p><strong>- Eye disorders</strong></p><p>Uncommon Vision blurred&nbsp;</p><p><strong>- Ear and labyrinth disorders</strong></p><p>Uncommon Tinnitus</p><p><strong>- Vascular disorders</strong></p><p>Uncommon Hypotension Respiratory,&nbsp;</p><p><strong>- thoracic and mediastinal disorders&nbsp;</strong></p><p>Uncommon Cough</p><p>Not known :&nbsp;&nbsp;Non cardiogenic pulmonary oedema&nbsp;</p><p><strong>- Gastrointestinal disorders&nbsp;</strong></p><p>Very rare : Diarrhoea&nbsp;</p><p><strong>- Musculoskeletal and connective tissue disorders&nbsp;</strong></p><p>Uncommon :&nbsp;&nbsp;Myalgia&nbsp;</p><p>Very rare : Arthralgia&nbsp;</p><p><strong>- Renal and urinary disorders&nbsp;</strong></p><p>Not known : Impaired renal function&nbsp;</p><p><strong>- General disorders and administration site conditions&nbsp;</strong></p><p>Uncommon : Fatigue&nbsp;</p><p><strong>- Investigations&nbsp;</strong></p><p>Not known : Serum uric acid increased, Serum bilirubin and Serum creatinine increased, Hypokalaemia, Hyponatraemia, Elevation of Blood Urea Nitrogen, Neutropenia</p><p>Frequency of adverse reactions with valsartan</p><p><strong>- Blood and lymphatic system disorders</strong></p><p>Not known : Decrease in haemoglobin, decrease in haematocrit, thrombocytopenia&nbsp;</p><p><strong>- Immune system disorders&nbsp;</strong></p><p>Not known : Other hypersensitivity/allergic reactions including serum sickness</p><p><strong>- Metabolism and nutrition disorders&nbsp;</strong></p><p>Not known : Increase of serum potassium,</p><p><strong>- hyponatraemia Ear and labyrinth disorders</strong></p><p>Uncommon: Vertigo</p><p><strong>- Vascular disorders</strong></p><p>Not known: Vasculitis</p><p>Gastrointestinal disorders&nbsp;</p><p>Uncommon : Abdominal pain&nbsp;</p><p><strong>- Hepatobiliary disorders&nbsp;</strong></p><p>Not known: Elevation of liver function values&nbsp;</p><p><strong>- Skin and subcutaneous tissue disorders</strong></p><p>Not known:&nbsp;&nbsp;Angioedema, rash, pruritus</p><p><strong>- Renal and urinary disorders</strong></p><p>Not known : Renal failure</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Symptoms Overdose with valsartan may result in marked hypotension, which could lead to depressed level of consciousness, circulatory collapse and/or shock. In addition, the following signs and symptoms may occur due to an overdose of the hydrochlorothiazide component: nausea, somnolence, hypovolaemia, and electrolyte disturbances associated with cardiac arrhythmias and muscle spasms.&nbsp;</p><p>Treatment :&nbsp;The therapeutic measures depend on the time of ingestion and the type and severity of the symptoms, stabilisation of the circulatory condition being of prime importance. If hypotension occurs, the patient should be placed in the supine position and salt and volume supplementation should be given rapidly. Valsartan cannot be eliminated by means of haemodialysis because of its strong plasma binding behaviour whereas clearance of hydrochlorothiazide will be achieved by dialysis.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Angiotensin II is formed from angiotensin I in a reaction catalyzed by angiotensin-converting enzyme (ACE, kininase II). Angiotensin II is the principal pressor agent of the renin-angiotensin system, with effects that include vasoconstriction, stimulation of synthesis and release of aldosterone, cardiac stimulation, and renal reabsorption of sodium. Valsartan blocks the vasoconstrictor and aldosterone-secreting effects of angiotensin II by selectively blocking the binding of angiotensin II to the AT1 receptor in many tissues, such as vascular smooth muscle and the adrenal gland. Its action is therefore independent of the pathways for angiotensin II synthesis. There is also an AT2 receptor found in many tissues, but AT2 is not known to be associated with cardiovascular homeostasis. Valsartan has much greater affinity (about 20,000-fold) for the AT1 receptor than for the AT2 receptor. The primary metabolite of valsartan is essentially inactive with an affinity for the AT1 receptor about one 200th that of valsartan itself. Blockade of the renin-angiotensin system with ACE inhibitors, which inhibit the biosynthesis of angiotensin II from angiotensin I, is widely used in the treatment of hypertension. ACE inhibitors also inhibit the degradation of bradykinin, a reaction also catalyzed by ACE. Because valsartan does not inhibit ACE (kininase II) it does not affect the response to bradykinin. Whether this difference has clinical relevance is not yet known. Valsartan does not bind to or block other hormone receptors or ion channels known to be important in cardiovascular regulation.&nbsp;</p><p>Blockade of the angiotensin II receptor inhibits the negative regulatory feedback of angiotensin II on renin secretion, but the resulting increased plasma renin activity and angiotensin II circulating levels do not overcome the effect of valsartan on blood pressure. Hydrochlorothiazide is a thiazide diuretic. Thiazides affect the renal tubular mechanisms of electrolyte reabsorption, directly increasing excretion of sodium and chloride in approximately equivalent amounts. Indirectly, the diuretic action of hydrochlorothiazide reduces plasma volume, with consequent increases in plasma renin activity, increases in aldosterone secretion, increases in urinary potassium loss, and decreases in serum potassium. The renin-aldosterone link is mediated by angiotensin II, so co administration of an angiotensin II receptor antagonist tends to reverse the potassium loss associated with these diuretics. The mechanism of the antihypertensive effect of thiazides is unknown.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Valsartan: Valsartan peak plasma concentration is reached 2 to 4 hours after dosing. Valsartan shows bi-exponential decay kinetics following intravenous administration, with an average elimination half-life of about 6 hours. Absolute bioavailability for the capsule formulation is about 25% (range 10%-35%). Food decreases the exposure (as measured by AUC) to valsartan by about 40% and peak plasma concentration (Cmax) by about 50%. AUC and Cmax values of valsartan increase approximately linearly with increasing dose over the clinical dosing range. Valsartan does not accumulate appreciably in plasma following repeated administration. Hydrochlorothiazide: The estimated absolute bioavailability of hydrochlorothiazide after oral administration is about 70%. Peak plasma hydrochlorothiazide concentrations (Cmax) are reached within 2 to 5 hours after oral administration. There is no clinically significant effect of food on the bioavailability of hydrochlorothiazide. Hydrochlorothiazide binds to albumin (40 to 70%) and distributes into erythrocytes. Following oral administration, plasma hydrochlorothiazide concentrations decline bi-exponentially, with a mean distribution half-life of about 2 hours and an elimination half-life of about 10 hours.</p><p>Distribution Valsartan: The steady state volume of distribution of valsartan after intravenous administration is small (17 L), indicating that valsartan does not distribute into tissues extensively. Valsartan is highly bound to serum proteins (95%), mainly serum albumin. Metabolism Valsartan: The primary metabolite, accounting for about 9% of dose, is valeryl 4-hydroxy valsartan. In vitro metabolism studies involving recombinantCYP 450 enzymes indicated that the CYP 2C9 isoenzyme is responsible for the formation of valeryl-4-hydroxy valsartan. Valsartan does not inhibit CYP 450 isozymes at clinically relevant concentrations. CYP 450 mediated drug interaction between valsartan and co-administered drugs are unlikely because of the low extent of metabolism. Hydrochlorothiazide: Is not metabolized. Excretion Valsartan: Valsartan, when administered as an oral solution, is primarily recovered in feces (about 83% of dose) and urine (about 13% of dose). The recovery is mainly as unchanged drug, with only about 20% of dose recovered as metabolites. Following intravenous administration, plasma clearance of valsartan is about 2 L/h and its renal clearance is 0.62 L/h (about 30% of total clearance). Hydrochlorothiazide: About 70% of an orally administered dose of hydrochlorothiazide is eliminated in the urine as unchanged drug.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&nbsp;Valsartan-Hydrochlorothiazide: No carcinogenicity, mutagenicity or fertility studies have been conducted with the combination of Diozad. However, these studies have been conducted for valsartan as well as hydrochlorothiazide alone. Based on the preclinical safety and human pharmacokinetic studies, there is no indication of any adverse interaction between Diozad. Valsartan: There was no evidence of carcinogenicity when valsartan was administered in the diet to mice and rats for up to 2 years at doses up to 160 and 200 mg/kg/day, respectively. These doses in mice and rats are about 2.6 and 6&nbsp;times, respectively, the maximum recommended human dose on a mg/m&sup2; basis. (Calculations assume an oral dose of 320 mg/day and a 60-kg patient.) Mutagenicity assays did not reveal any valsartan-related effects at either the gene or chromosome level. These assays included bacterial mutagenicity tests withSalmonella (Ames) and E. coli; a gene mutation test with Chinese hamster V79 cells; a cytogenetic test with Chinese hamster ovary cells; and a rat micronucleus test. Valsartan had no adverse effects on the reproductive performance of male or female rats at oral doses up to 200 mg/kg/day. This dose is about 6 times the maximum recommended human dose on a mg/m&sup2; basis. (Calculations assume an oral dose of 320 mg/day and a 60-kg patient.) Hydrochlorothiazide: Two-year feeding studies in mice and rats conducted under the auspices of the National Toxicology Program (NTP) uncovered no evidence of a carcinogenic potential of hydrochlorothiazide in female mice (at doses of up to approximately 600 mg/kg/day) or in male and female rats (at doses of up to approximately 100 mg/kg/day). The NTP, however, found equivocal evidence for hepatocarcinogenicity in male mice. Hydrochlorothiazide was not genotoxic in vitro in the Ames mutagenicity assay of Salmonella Typhimurium strains TA 98, TA 100, TA 1535, TA 1537, and TA 1538 and in the Chinese Hamster Ovary (CHO) test for chromosomal aberrations, or in vivo in assays using mouse germinal cell chromosomes, Chinese hamster bone marrow chromosomes, and the Drosophila sex-linked recessive lethal trait gene. Positive test results were obtained only in the in vitro CHO Sister Chromatid Exchange (clastogenicity) and in the Mouse Lymphoma Cell (mutagenicity) assays, using concentrations of hydrochlorothiazide from 43 to 1300 mcgm/mL, and in the Aspergillus Nidulans non-disjunction assay at an unspecified concentration. Hydrochlorothiazide had no adverse effects on the fertility of mice and rats of either sex in studies wherein these species were exposed, via their diet, to doses of up to 100 and 4 mg/kg, respectively, prior to mating and throughout gestation. These doses of hydrochlorothiazide in mice and rats represent 19 and 1.5 times, respectively, the maximum recommended human dose on a mg/m&sup2; basis. (Calculations assume an oral dose of 25 mg/day and a 60-kg patient.)<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Microcrystalline Cellulose, Crospovidone, Colloidal silicon dioxide, Magnesium stearate, Opadry Pink (80/12.5 mg and 320/25 mg), Opadry Brown (160/12.5 mg, 160/25 mg), Opadry Yellow (320/12.5) and Purified water.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>-&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                3 Years 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30 C. Store in the original carton in order to protect from light.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Round white PVC, Alu BLISTER Container.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Razi Al Madina Pharamceuticals 
Industrial City St.48 
Al Madina Almunawarrah, Medina 
Tel : 009661486907211
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                05/2017
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>